These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35233055)

  • 1. Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation.
    Yang SY; Kang DW; Nam JH; Choi EK; Lee EK; Shin JY; Kwon SH
    Sci Rep; 2022 Mar; 12(1):3413. PubMed ID: 35233055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
    Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
    J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic Stenosis and Outcomes in Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Teppo K; Airaksinen KEJ; Biancari F; Jaakkola J; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Hartikainen J; Aro AL; Lehto M
    J Am Heart Assoc; 2023 May; 12(9):e029337. PubMed ID: 37119067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.
    Hernandez I; He M; Brooks MM; Saba S; Gellad WF
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):199-207. PubMed ID: 31523759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study.
    Srikajornlarp S; Amnueypol M; Vathesatogkit P; Numthavaj P; Ungkanont A; Likittanasombat K; Pattanaprateep O; Angchaisuksiri P; Boonyawat K
    Clin Appl Thromb Hemost; 2022; 28():10760296221130058. PubMed ID: 36198021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.
    Gupta K; Trocio J; Keshishian A; Zhang Q; Dina O; Mardekian J; Nadkarni A; Shank TC
    BMC Cardiovasc Disord; 2019 Jun; 19(1):142. PubMed ID: 31195999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: Insights from MISOAC-AF trial.
    Patsiou V; Samaras A; Kartas A; Moysidis DV; Papazoglou AS; Bekiaridou A; Baroutidou A; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiol; 2023 Apr; 81(4):390-396. PubMed ID: 36179772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation.
    Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC
    J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.
    Moon I; Go TH; Kim JY; Kang DR; Sohn SH; Lee HJ; Choi JW; Park JB; Hwang HY; Kim HK; Kim YJ; Kim KH; Lee SP
    PLoS One; 2022; 17(6):e0268113. PubMed ID: 35700183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
    Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
    CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
    Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
    J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study.
    Mohan A; Majd Z; Trinh T; Paranjpe R; Abughosh SM
    Int J Clin Pharm; 2022 Aug; 44(4):966-974. PubMed ID: 35776377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
    Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
    Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.